|
|||
2016-04-12 22:21:05 CEST 2016-04-12 22:21:05 CEST BIRTINGARSKYLDAR UPPLÝSNINGAR Biotie Therapies - Major shareholder announcementsDisclosure under Chapter 9, Section 5 of the Finnish Securities Markets ActBIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 12 April, 2016 at 11.20 p.m. Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act Biotie Therapies Corp. (Nasdaq Helsinki BTH1V; NASDAQ: BITI) ("Biotie" or the "Company") has on April 12, 2016 received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act ("SMA") from Mr. Samuel D. Isaly on behalf of himself and OrbiMed Advisors LLC, OrbiMed Capital GP V LLC and OrbiMed Private Investments V, LP. According to the notification, the total number of Biotie shares owned directly or through financial instruments by Samuel D. Isaly and entities under his control has fallen below the threshold of 5 per cent on April 11, 2016. Biotie's registered total number of shares and voting rights amounting to 1,089,608,083 has been used in the calculation of percentages for the announcement. Total positions of Samuel D. Isaly and entities under his control subject to the notification: +-----------------------+----------------+---------------------+---------------+ | |% of shares and |% of shares and |Total of both | | |voting rights |voting rights through|in % (A + B) | | |(total of A) |financial instruments| | | | |(total of B) | | +-----------------------+----------------+---------------------+---------------+ |Resulting situation on |Below 5 % |Below 5 % |Below 5 % | |the date on which | | | | |threshold was crossed | | | | |or reached | | | | +-----------------------+----------------+---------------------+---------------+ |Position of previous |6.76 |4.78 |11.54 | |notification (if | | | | |applicable) | | | | +-----------------------+----------------+---------------------+---------------+ Notified details of the resulting situation on the date on which the threshold was crossed or reached: A: Shares and voting rights +-----------------------+---------------------------+--------------------------+ |Class/type of shares |Number of shares and voting|% of shares and voting | |ISIN code (if possible)|rights |rights | | +---------+-----------------+---------+----------------+ | |Direct |Indirect |Direct |Indirect | | |(SMA 9:5)|(SMA 9:6 and 9:7)|(SMA 9:5)|(SMA 9:6 and | | | | | |9:7) | +-----------------------+---------+-----------------+---------+----------------+ |Shares |- |- |- |- | |(FI0009011571) | | | | | +-----------------------+---------+-----------------+---------+----------------+ |American Depositary |- |- |- |- | |Shares (ADS), each | | | | | |representing 80 Shares | | | | | |(FI0009011571) | | | | | +-----------------------+---------+-----------------+---------+----------------+ |SUBTOTAL A | |Below 5 % | +-----------------------+---------------------------+--------------------------+ B: Financial instruments according to SMA 9:6a +-----------------+-------------+-------------+-------------+---------+--------+ |Type of financial|Expiration |Exercise/ |Physical or |Number of|% of | |instrument |date |Conversion |cash |shares |shares | | | |period |settlement |and |and | | | | | |voting |voting | | | | | |rights |rights | +-----------------+-------------+-------------+-------------+---------+--------+ |Warrants |Nov 1, 2020 |Nov 1, 2015 -|Physical |- |- | |entitling to | |Nov 1, 2020 |settlement | | | |subscribe for | | | | | | |Shares | | | | | | |(FI0009011571) | | | | | | +-----------------+-------------+-------------+-------------+---------+--------+ |SUBTOTAL B | |Below 5 | | | |% | +-------------+---------+--------+ Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity: +-----------------------+-----------------+----------------------+-------------+ |Name |% of shares and |% of shares and voting|Total of both| | |voting rights |rights through | | | | |financial instruments | | +-----------------------+-----------------+----------------------+-------------+ |Samuel D. Isaly |Below 5 % |Below 5 % |Below 5 % | +-----------------------+-----------------+----------------------+-------------+ |OrbiMed Advisors LLC |Below 5 % |Below 5 % |Below 5 % | +-----------------------+-----------------+----------------------+-------------+ |OrbiMed Capital GP V |Below 5 % |Below 5 % |Below 5 % | |LLC | | | | +-----------------------+-----------------+----------------------+-------------+ |OrbiMed Private |Below 5 % |Below 5 % |Below 5 % | |Investments V, LP | | | | +-----------------------+-----------------+----------------------+-------------+ According to the notification, Samuel D. Isaly is the managing member of and owner of a controlling interest in OrbiMed Advisors LLC, which is the sole managing member of OrbiMed Capital GP V LLC. OrbiMed Capital GP V LLC is the general partner of OrbiMed Private Investments V, LP. Further, according to the notification neither Samuel D. Isaly nor any other entity under his control holds shares or financial instruments in the Company exceeding a notification threshold. In Turku, April 12, 2016 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp. tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com DISTRIBUTION: Nasdaq Helsinki Ltd Main Media www.biotie.com [HUG#2003005] |
|||
|